With surveillance, conversion to acute valve syndrome happened frequently and was linked to worse clinical outcomes.

Patients with severe aortic stenosis had comparable rates of death or disabling stroke, but the lead investigator cautions ...

Without treatment, 1 in 10 patients experiencing symptoms of severe aortic stenosis (AS) may die within five weeks. However, the symptoms of severe AS can be difficult to detect and may progress ...

BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...

The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients ...

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter ...

Aortic stenosis is usually a slowly progressive disease ... Examination revealed moderately severe congestive heart failure. The heart seemed moderately enlarged and there was a Grade III rough ...

Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...

Medtronic (NYSE: MDT) stock was a fairly hot item as the trading week kicked off, with investors pushing the shares up by ...

Aortic stenosis is a condition where the aortic valve narrows, obstructing blood flow from the heart to the aorta. As a ...